Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...
UK MHRA grants marketing authorisation to AstraZeneca’s eplontersen to treat adults with rare inherited nerve disease or polyneuropathy: United Kingdom Friday, October 18, 2024, ...